TNF-α, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue
Open Access
- 1 June 2005
- journal article
- clinical trial
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 98 (6) , 2019-2023
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is produced by adipose tissue, and elevated PAI-1 levels in plasma are a risk factor in the metabolic syndrome. We investigated the regulatory effects of TNF-α and IL-6 on PAI-1 gene induction in human adipose tissue. Twenty healthy men underwent a 3-h infusion of either recombinant human TNF-α (n = 8), recombinant human IL-6 (n = 6), or vehicle (n = 6). Biopsies were obtained from the subcutaneous abdominal adipose tissue at preinfusion, at 1, 2, and 3 h during the infusion, and at 2 h after the infusion. The mRNA expression of PAI-1 in the adipose tissue was measured using real-time PCR. The plasma levels of TNF-α and IL-6 reached 18 and 99 pg/ml, respectively, during the infusions. During the TNF-α infusion, adipose PAI-1 mRNA expression increased 2.5-fold at 1 h, 6-fold at 2 h, 9-fold at 3 h, and declined to 2-fold 2 h after the infusion stopped but did not change during IL-6 infusion and vehicle. These data demonstrate that TNF-α rather than IL-6 stimulates an increase in PAI-1 mRNA in the subcutaneous adipose tissue, suggesting that TNF-α may be involved in the pathogenesis of related metabolic disorders.Keywords
This publication has 50 references indexed in Scilit:
- Direct attenuation of plasminogen activator inhibitor type-1 expression in human adipose tissue by thiazolidinedionesThrombosis and Haemostasis, 2004
- IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohortAtherosclerosis, 2003
- Relationship between IL-6, Leptin and Adiponectin and Variables of Fibrinolysis in Overweight and Obese Hypertensive PatientsHormone and Metabolic Research, 2002
- Visceral Fat is a Determinant of PAI-1 Activity in Diabetic and Non-Diabetic Overweight and Obese WomenHormone and Metabolic Research, 2001
- Disruption of the plasminogen activator inhibitor‐1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob miceThe FASEB Journal, 2001
- Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 DiabetesTrends in Endocrinology & Metabolism, 2000
- A High Plasma Concentration of TNF- Is Associated With Dementia in CentenariansThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1999
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Secretory products of macrophages.Journal of Clinical Investigation, 1987